You can purchase shares of Liquidia (NASDAQ:LQDA) through any online brokerage.

View our list of the best stock brokerages

Other companies in Liquidia’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Phibro Animal Health Corp (NASDAQ:PAHC), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and Axsome Therapeutics Inc (NASDAQ:AXSM).

Liquidia has a consensus price target of $35.27.

The stock price for Liquidia (NASDAQ: LQDA) is $39.01 last updated April 14, 2026 at 12:43 AM EDT.

There are no upcoming dividends for Liquidia.

Liquidia does not have any upcoming earnings scheduled.

There is no upcoming split for Liquidia.

Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.